Liverpool biocampus mulls LABV

10 April 2012 The Royal Liverpool and Broadgreen University Hospitals Trust (RLBUHT) is considering using a local asset-backed vehicle (LABV) approach to build a new £28m life science and innovation centre.
On behalf of the University of Liverpool and Liverpool City Council, the Trust is seeking to market test private contractors to see how Liverpool's new Bio Innovation Centre - the the first phase of the delivery of an international life science bio-campus - could be financed and built. 

The authority is looking for feedback on whether to procure the building using Procure 21+, a restricted negotiated procedure or a local asset-backed vehicle company.

The deal will involve the construction of a new innovation centre "to connect academics, industry professionals, investors, clinicians and the NHS", according to a statement. The centre will be built on a 10 hectare site in the ownership of RLBUHT, with full planning permission for commercial and research development.

The institutions' key objective is for the new campus to place Liverpool alongside Boston and Singapore as a leading international centre for the life sciences. Procurement works are hoped to begin by the end of 2012 with the centre being in full operation by May 2014.

This page was last updated on:
16 June 2015.

thumb

Danish intrigue

Viewers of the increasingly popular Danish dramas such as Borgen, The Killing and The Bridge will be well used to plot twists and political surprises that influence daily life in the kingdom.

thumb

No Time to Lose

Galliford Try’s Mark Baxter is hoping to have two and a half markets to tackle in the coming years. He tells Paul Jarvis that UK authorities need to build while the debt remains cheap

register

Register now to get un-restricted access to all sections of the website.

Want to see more first? Try our free preview...